Sjögren syndrome in obstetric and gynecology: Literature review;Syndrome de Gougerot-Sjögren en gynécologie obstétrique: Revue de la littérature

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 35, Issue 2, 2006, Pages 169-175

  Picone, O ^a   Alby, C ^a   Frydman, R ^a   Mariette, X ^b  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Congenital atrioventricular hart block; Neonatal lupus; Obstetrics and Gynecology; Sj gren syndrome

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; PILOCARPINE; ANDROGEN; ESTROGEN;

ATRIOVENTRICULAR BLOCK; CONJUNCTIVITIS; CONTRACEPTION; DISEASE ASSOCIATION; DISEASE COURSE; EXOCRINE GLAND; FERTILITY; HEALTH CARE; HEALTH PROGRAM; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; INTENSIVE CARE UNIT; LUPUS ERYTHEMATOSUS; MEDICAL SPECIALIST; MORBIDITY; MUCOSAL DRYNESS; NEWBORN PERIOD; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; RISK ASSESSMENT; SEXUALITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS RASH; AUTOIMMUNE DISEASE; FEMALE; GYNECOLOGY; HEART BLOCK; NEWBORN; NEWBORN DISEASE; OBSTETRICS; PREGNANCY COMPLICATION; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ANDROGENS; AUTOIMMUNE DISEASES; ESTROGENS; FEMALE; GYNECOLOGY; HEART BLOCK; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; SJOGREN'S SYNDROME; VIRUS DISEASES;

EID: 33646673123     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(06)76391-8     Document Type: Review

References (46)

1. e Edition, 1997 ; Volume 2, pp. 1301-17.
2. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004; 164: 1275-84.
3. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43.
4. Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994; 72: 162-5.
5. Aractingi S, Sibilia J, Meignin V, Launay D, Hachulla E, Le Danff C et al. Presence of microchimerism in labial salivary glands in systemic sclerosis but non in Sjögren syndrome. Arthritis Rheum 2002; 46: 1039-43.
6. Endo Y, Negishi I, Ishikawa O. Possible contribution of microchimerism to the pathogenesis of Sjögren's syndrome. Rheumatology 2002; 41: 490-5.
7. Kuroki M, Okayama A, Nakamura S, Sasaki T, Muari K, Shiba R et al. Detection of maternal-fetal microchimerism in the inflammatory lesions of patients with Sjögren syndrome. Ann Rheum Dis 2002; 61: 1041-6.
8. Giacomelli R, Matucci-Cerinic M, Bombardieri S. Microchimerism in Sjögren's syndrome. Ann Rheum Dis 2002; 61: 1039-40.
9. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 1991; 90: 286-94.
10. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 1994; 944: 1116-9.
11. Mariette X, Agbalika F, Zuker Franklin D Clerc D, Janin A, Cherot P et al. Detection of the tax gene of HTLV-1 in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity. Clin Exp Rheumatol 2000; 18: 341-7.
12. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P, Beaugrand M. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-3.
13. Mariette X. Pathophysiology of Sjögren's syndrome. Ann Med Intern 2003; 154: 157-68.
14. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al.; European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjögren's syndrome : a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
15. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al. Chused TM Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89: 888-92.
16. van Vollenhoven RF. Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacopther 2003; 3: 23-31.
17. Sullivan DA, Belanger A, Cermak JM, Berube R, Papas AS, Sullivan RM et al. Are women with Sjogren's syndrome androgen deficient? J Rheumatol 2003; 30: 2413-9.
18. Sato E. Comparative influence of steroid hormones and immonusuppresive agents on autoimmune expression in lacrymal glands on female mouse model of Sjogren's syndrome. Invest OphtalmolVis Sci 1994; 34: 2632-42.
19. Valtysdottir S Th, Wide L, Hallgren R. Mental well being and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Theum Dis 2003; 62: 875-9.
20. Pillemer SR, Brennan MT, Sankar V, Leakan RA, Smith JA, Grisius M et al. Pilot clinical trial of Dehydroepiandrosterone (DHEA) versus placebo for Sjogren's Syndrome. Arhtritis Rheum 2004; 51: 601-4.
21. Tayim S, Haghighat N, Al-Ashimi I. A comparison of the hormon levels in patients with SJogren's syndrome and healthy controls. Oral Surg Oral Med Oral Radiol Endod 2004; 97: 579-83.
22. Hayashi Y, Arakaki R, Ishimaru N. Apoptosis and estrogen deficiency in primary Sjogren syndrome. Curr Opin Rheumatol 2004; 16: 522-6.
23. Brennat MT, Sankar V, Leakan RA, Grisius MM, Collins MT, Fox J et al. Sex hormones in primary Sjogren syndrome. J Rheumatol 2003; 30: 1267-71.
24. Haga HJ, Gjesdal CG, Irgens LM, Ostensen M. Reproduction and gynaecological manifestations in women with primary Sjogren's syndrome: a case-control study. Scand J Rheumatol 2005; 34: 45-8.
25. Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM. Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis 1994; 53: 569-73.
26. Marchesoni D, Mozzanega B, De Sandre P, Romagnolo C, Gambari I, Maggino T. Gynaecological aspects of primary Sjögren's syndrome. Eur J Obstet Gynecol Reprod Biol 1995; 63: 49-53.
27. Capriello P, Barale E, Cappelli N, Lupo S, Teti G. Sjögren's syndrome: clinical, cytological, histological and colposcopic aspects in women. Clin Exp Obstet Gynecol 1988; 15: 9-12.
28. Mulherin DM, Sheeran TP, Kumararatne DS, Speculand B, Lusley, Situnayake RD. Sjögren's syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 1997; 104: 1019-23.
29. Manthorpe T, Manthorpe R. Congenital complete heart block in children of mothers with primary Sjögren's syndrome. Lancet 1992; 340: 1359-60.
30. Manthorpe R, Svensson A, Wirestrand LE. Late neonatal lupus erythematosus onset in a child born of a mother with primary Sjögren's syndrome. Ann Rheum Dis 2004; 63: 1496-7.
31. Buyon JP, Clancy RM. Auto-antibody associated heart-block: TGF Beta and the road to scar. Autoimm Rev 2005; 4: 1-7.
32. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5.
33. Van Bergen AH, Cuneo BF, Davis N. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren's antibodies. Am J Obstet Gynecol 2004; 191: 1014-8.
34. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Georgin S, Vauthier D, Sebbouh D et al. Neonatal lupus syndrome: review of the literature. Rev Med Intern 2003; 24: 659-71.
35. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Thi Huong du L, Denjoy I, Vauthier D et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004; 50: 3187-94.
36. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003; 62: 1010-2.
37. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004, 110: 1542-8.
38. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999; 42: 2335-45.
39. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999; 34:1190-6.
40. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001; 37: 238-42.
41. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000; 137: 674-80.
42. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002; 109: E11.
43. Prendiville JS, Cabral DA, Poskitt KJ, Au S, Sargent MA. Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol 2003; 20: 60-7.
44. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL, Tran-Johnson TK et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren's syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 1999; 159: 174-81.
45. Nusair, S, Rubinow. The use of oral pilocarpine in xerostomia and Sjogren's syndrome. Semin arthritis Rheum 1999; 28: 360-7.
46. Mariette X. Current and potential treatments for primary Sjogren's syndrome. Joint Bone Spine 2002; 69: 363-6